Evidence map›Paper›PMID 41030672›Full record

ArticleJAC-antimicrobial resistance2025

The 2025 EQUAL

Luise Haensel, Rosanne Sprute, Jan Grothe, Florence Robert-Gangneux, Jean-Pierre Gangneux, Jacques F Meis, Oliver A Cornely, Philipp Koehler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luise HaenselFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Herderstrasse 52, Cologne, NRW 50931, Germany.ORCID https://orcid.org/0000-0002-4494-5159
Rosanne SpruteFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Herderstrasse 52, Cologne, NRW 50931, Germany.ORCID https://orcid.org/0000-0003-2457-6437
Jan GrotheFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Herderstrasse 52, Cologne, NRW 50931, Germany.ORCID https://orcid.org/0000-0001-8498-231X
Florence Robert-GangneuxMycology Department, Excellence Center for Medical Mycology (ECMM) and French National Center for Chronic Aspergillosis, Rennes University Hospital, Rennes, France.ORCID https://orcid.org/0000-0003-4493-596X
Jean-Pierre GangneuxMycology Department, Excellence Center for Medical Mycology (ECMM) and French National Center for Chronic Aspergillosis, Rennes University Hospital, Rennes, France.ORCID https://orcid.org/0000-0002-4974-5607
Jacques F MeisFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Herderstrasse 52, Cologne, NRW 50931, Germany.ORCID https://orcid.org/0000-0003-3253-6080
Oliver A CornelyFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Herderstrasse 52, Cologne, NRW 50931, Germany.ORCID https://orcid.org/0000-0001-9599-3137
Philipp KoehlerFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Herderstrasse 52, Cologne, NRW 50931, Germany.ORCID https://orcid.org/0000-0002-7386-7495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Objectives: To develop a scoring tool and quality indicator that facilitates clinical decision making and quantifies adherence to best-practice guidelines for PCP in patients with and without HIV. Methods: Key recommendations for the diagnosis, treatment and follow-up of PCP were extracted from current guidelines of the European Council on Infections in Leukaemia (ECIL), the American Society of Transplantation Infectious Diseases Community of Practice (AST-IDCOP), and the IDSA guidelines. Each recommendation was assigned a point value ranging from -1 to 3, weighted according to the strength of recommendation and level of evidence. Results: The proposed 2025 European Confederation of Medical Mycology (ECMM) QUALity (EQUAL) Conclusions: The 2025 EQUAL

Identifiers

PMID41030672
PMCPMC12477467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.